Abstract
Introduction: The diagnosis of pancreatic ductal adenocarcinoma (PDAC) is seldom straightforward and often time consuming, especially when the presenting symptoms and/or radiological features are similar to benign diseases such as chronic pancreatitis (CP). Evidently, there is a need for novel markers, which can accurately discriminate between PDAC and benign conditions. The current study aims to examine the diagnostic potential of Cytokines, Chemokines, and Growth Factors (CCGFs) for PDAC.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
